Hepatitis and Liver Health - Hepatitis - Liver Health - Hep C - Hep B - Hep A
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:
HCV Vaccine
1
2
3
4
5
6
7
8

THIS JUST IN
Our top stories and the best of everything else out there
> Blogs > Forums > Hepatitis News > Hep Exclusives > Lessons


Risky Mixes

9 ways to help reduce your risk of drug interactions during hep C treatment.



Treatment Details

From adherence troubles to insomnia and irritability, Greg Jeffries goes over his experience.



Blood Fear

A blog on worrying about infecting other people—and wondering if they can infect you.



Double Check Your References!

Rick Nash: Something’s off with the CDC’s estimated HCV rate for incarcerated individuals.



A Letter to Hepatitis C

“You are in me, but you don’t own me,” writes Matt Starr.



Road Trip!

Tips for traveling with advanced liver disease from blogger, Rick Nash.



Going Back
to Bed

Post-transplant, Karen Hoyt talks about the importance of rest for recovery.



Everyday Life

Walking through a typical day of hepatitis C with mom blogger, Kim Bossley.


New Viral Hepatitis Numbers

An in-depth look at the CDC’s latest hepatitis A, B and C infection stats.



Viekira Pak Cures 100%

Cirrhotic Genotype 1bs fare well on AbbVie’s new hepatitis C combo.



Reinfection Risks

Should injection drug users get access to hep C treatment?



Goodbye to the Boys on
the Bus

A veteran’s compelling story about curing his hepatitis C through the VA.



Mixed Results

GlobeImmune’s new hep B treatment lacks strength in Phase II trials.



Competing Viruses

HCV may actually inhibit HBV among people infected with both liver diseases.



An Uphill Climb

Will we ever have a preventative hepatitis C vaccine?



Treatment as Prevention

Scaling up hep C therapy among gay men in the UK halves new cases.


Your Online Hepatitis Community

Check out what everyone's talking about in the Hep Forums.



Hep Lesson: Hepatitis C Symptoms

Many people with chronic HCV have no signs of infection. Others have a much harder time.



China Rejects Sovaldi Patent

Treatment access activists once again argued the drug’s formulation is not truly innovative.



Obamacare Upheld!

The Affordable Care Act marks another major victory in the Supreme Court.



Is That Legal?

Veterans Affairs launches a controversial plan to outsource its hepatitis C care.



Treatment Access Victory

Connecticut pushes to make hep C cures easier for low-income patients.



Hep C Lawsuit

Massachusetts inmates sue the state’s prison system for hepatitis C treatment.



Prison Injustice

Louisiana appeals court denies federal judge’s call to release ‘Angola 3’ inmate with HCV.


TREATMENT
Research updates
> More Treatment News


HEP NEWS
Latest headlines
> More Hep News

FOCUS ON
Hot topics
Newly Diagnosed
Real People, Real Stories
Nutrition and Exercise
Hep C and Depression
Help Paying for Meds
Joining Clinical Trials


EXCLUSIVES
Online coverage
> More Exclusives

BLOGS
Rants and raves
Lucinda Rick Connie
Matt Karen Joe

More Blogs

FORUMS
Community support
“Has anyone else had the situation of extremely high viral loads (11 million+) but low LFT's and other markers (fibrosis 1, no cirrhosis)? I've most likely had this in my system for almost 40 years, with no symptoms that I am aware of. How urgent is treatment at this point?”
New York Girl’s “Anyone have very high viral load but no symptoms and low other markers?”

“Today I received a letter from the independent medical review company, saying that the denial of Harvoni by Anthem had been overturned! It has been a hugely long process, but if you’ve had denials and haven’t requested an external review, I highly encourage it.”
BDK’s “Appeal, Appeal, Appeal”

> More Forums
             
FEATURED VIDEO
Inventor of Sofosbuvir discusses limited patient access to drug.
> More Hep TV

HEP MAGAZINE

Current Issue
Hep Archives
Hep Digital
Hep Newsletter
Bulk Subscriptions

TALK TO US
Tell us what you think
Poll
Do you experience any symptoms of hepatitis C infection?
Yes
No

Survey
Hepatitis C Reader Survey

MOST POPULAR
What you're reading
FDA Approves Gilead's Hep C Drug Harvoni
Patient Assistance and Co-Pay Programs for Viral Hepatitis Drugs
Treating Hep C in Six Weeks May Be Possible With Achillion Drug
Tattoos and Hepatitis C: What Are the Risks?
12 Weeks of Harvoni and Ribavirin Cures 96% of Cirrhotics With HCV
Harvoni Posts Good Cure Rates for Hepatitis Genotypes 3 and 6
Do Interferon-Free Hep C Treatments Have Side Effects?

HEP ON TWITTER
© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.